Clinical Trial Update: Apremilast for Chronic Plaque Psoriasis (CPP) Patients Who Have Failed One Course of Biologic Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of apremilast for chronic plaque psoriasis in patients who failed biologic therapy was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Duke University | Conditions: Chronic Plaque Psoriasis | Phase 2 | Status: WITHDRAWN